“从目前媒体报道的情况来看,葛兰素史克(以下简称GSK)事件可能只是一个由头,而相关部门的真正目的是逼迫药企降价”。近日,一位分析人士接受《每日经济新闻》记者采访时表示。虽然公安部门针对GSK的调查尚未结束,但随着相关细节逐步披露,一个外企在中国通过违法手段促销药品的路线图逐渐清晰。最近有报道称,GSK总部正向上海派遣高级内部审计师和律 “From the current media coverage of the situation, GSK (GSK) incident may be just a head start, and the real purpose of the relevant departments is to force drug prices ”. Recently, an analyst accepted the “Daily Economic News” reporter said in an interview. Although the public security department’s investigation of GSK has not ended yet, as the relevant details are gradually revealed, a roadmap for the promotion of drugs by foreign companies in China through illegal means is gradually clear. It has recently been reported that GSK headquarters is sending senior internal auditors and law to Shanghai